Josh Mandel-Brehm

Josh Mandel-Brehm serves as CEO at CAMP4 Therapeutics. CAMP4 Therapeutics operates in the research sector with approximately 68.0 employees. The company is headquartered in Boston, Massachusetts. CAMP4 Therapeutics generates annual revenue of 652000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 3,781 executive contacts are available in Massachusetts.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 Flywheel Adobe Marketing Cloud WordPress.org Google Analytics Mobile Friendly Bootstrap Framework Typekit Google Tag Manager Remote

biotechnology research rna gene expression regulatory rna programmable therapeutics rna actuators antisense oligonucleotides aso therapy genetic diseases protein expression tunability mrna amplification gene regulation drug discovery therapeutic candidates clinical-stage pipeline development biotechnology disease treatment molecular biology therapeutic innovation genetic modification central nervous system diseases liver diseases therapeutic strategy genetic mutations protein production rna-targeting therapeutic platform bioengineering drug delivery precision medicine immune modulation synthetic gene regulation genetic therapies molecular therapeutics crispr technology regrna mapping therapeutic design biopharma partnerships dna-rna interaction gene therapy rna therapeutics cell-specific delivery designer drugs vascular diseases non-coding rna clinical trials health care health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Josh Mandel-Brehm in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at CAMP4 Therapeutics.

Josh Mandel-Brehm's Position in the MessageCEO Database

• •Josh Mandel-Brehm is 1 of 1 verified executive contact we track at CAMP4 Therapeutics.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •3,577 verified executive contacts in Massachusetts are in the database.
• •25 verified contacts work at research companies in the 68.0 employee range (same size as CAMP4 Therapeutics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Josh Mandel-Brehm directly?

Josh Mandel-Brehm's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at CAMP4 Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Josh Mandel-Brehm work for?

Josh Mandel-Brehm is CEO at CAMP4 Therapeutics, a company in the research sector with 68.0 employees. The company is based in Boston, Massachusetts.

Can I pitch or sell to Josh Mandel-Brehm?

As CEO at CAMP4 Therapeutics, Josh Mandel-Brehm is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Josh Mandel-Brehm directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Josh Mandel-Brehm in?

Josh Mandel-Brehm works in the research industry as CEO at CAMP4 Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Josh Mandel-Brehm's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Josh Mandel-Brehm's profile is kept up-to-date with the latest available information.

Last updated: July 21, 2026